pirinixic acid has been researched along with Eczema, Atopic in 3 studies
pirinixic acid: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, Y | 1 |
| Elias, PM | 1 |
| Crumrine, D | 1 |
| Feingold, KR | 1 |
| Katagiri, K | 1 |
| Fujiwara, S | 1 |
| Chiba, T | 1 |
| Takeuchi, S | 1 |
| Esaki, H | 1 |
| Yamamura, K | 1 |
| Kurihara, Y | 1 |
| Moroi, Y | 1 |
| Furue, M | 1 |
| Staumont-Sallé, D | 1 |
| Abboud, G | 1 |
| Brénuchon, C | 1 |
| Kanda, A | 1 |
| Roumier, T | 1 |
| Lavogiez, C | 1 |
| Fleury, S | 1 |
| Rémy, P | 1 |
| Papin, JP | 1 |
| Bertrand-Michel, J | 1 |
| Tercé, F | 1 |
| Staels, B | 1 |
| Delaporte, E | 1 |
| Capron, M | 1 |
| Dombrowicz, D | 1 |
3 other studies available for pirinixic acid and Eczema, Atopic
| Article | Year |
|---|---|
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.
Topics: Adjuvants, Immunologic; Animals; Clobetasol; Dermatitis, Atopic; Disease Models, Animal; Drug Synerg | 2011 |
Topical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga mice.
Topics: Animals; Dermatitis, Atopic; Disease Models, Animal; Eosinophils; Epidermis; Female; Immunoglobulin | 2012 |
Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Animals; Bronchial Hyperreactivity; Derma | 2008 |